Press Release: Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT(R) Platform in Man-Made Cellulosic Fibers and Materials
Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT(R) Platform in Man-Made Cellulosic Fibers and Materials
Newly-Issued Patent Expands the Company's Patent Estate in Textile Supply Chain Solutions
STONY BROOK, N.Y.--(BUSINESS WIRE)--January 27, 2020--
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions, nucleic acid-based biotherapeutic development and liquid biopsies, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it United States patent no. 10,519,605 entitled "Methods of Marking Cellulosic Products." The newly-issued patent covers methods of tagging man-made cellulosic (MMC) fibers or materials with a nucleic acid (DNA) tag during production and later authenticating the nucleic acid-tagged MMC fibers and/or materials via PCR-based detection techniques to confirm provenance and/or authenticity.
Global MMC production volume more than doubled from 3 million (in 1990) to 6.7 million metric tons in 2018(1) , and is expected to continue to grow at an annual rate of 9% through 2024(2) . MMCs include viscose, Rayon, acetate, lyocell, Tencel(R) , modal and cupro materials.
Most MMCs are primarily derived from wood. Heightened awareness related to the sourcing of wood raw materials from endangered or ancient forests, the social and environmental concerns relating to the chemicals used in production, as well as the amount of energy and water used to manufacture MMCs, has led to greater oversight of the MMC industry and requires proof that these materials come from controlled and sustainable sources that can be verified by scientific evidence.
"The use of MMC fibers and materials is moving the textile industry towards greater sustainability, but has also yielded social and environmental concerns related to deforestation and biodiversity. In response, brands and retailers, such as H&M Group that has articulated a goal to only use MMC fibers from certified, responsibly-managed sources in its products by 2025(3) , are actively strengthening their sourcing policies to address these concerns. Central to their initiatives is traceability of their MMC supply chains to feedstock levels," said MeiLin Wan, Vice President of Textile Sales at Applied DNA. "With these new patents, together with our linear DNA-based tagging platform, we can offer MMC fiber producers and manufacturers the unparalleled ability to ensure that their brands are real and safe."
"Transparency related to the source, origin and authenticity of MMCs is the key to unlock valuable claims related to sustainable and ethical sourcing -- and this is important for the supply chain to know that their product and brand is secure from source to shelf," said Wayne Buchen, Vice President of Strategic Sales at Applied DNA. "The Company continues to collaborate with its global network of MMC fiber producers and manufacturers to assure that their brands are verified and traceable. With increased scrutiny of cellulosic fibers originating from certain geographic locations, we plan to provide solutions to enable our partners to digitally verify their products through our CertainT portal, and also help our brand partners to authenticate their products through additional solutions that we offer for protecting hang tags, thread and packaging. We are very excited to now offer our patented technology to all stakeholders in the cellulosic fiber and materials value chain."
"The Company is at the forefront of large-scale PCR-based DNA manufacture innovation as shown by its over 130 pending patent applications and issued patents," said Dr. James A. Hayward, chairman, president and CEO of Applied DNA. "With the issuance of this patent, we continue to expand the value of our proprietary CertainT platform in textiles, which will be a key focus for fiscal 2020."
(1) Textiles Exchange, Preferred Fiber & Materials, Market Report 2019
(2) https://www.marketwatch.com/press-release/2019-24-cellulose-fiber-market-to-register-usd-39-bn-revenue-2019-07-22
(3) https://hmgroup.com/sustainability/Planet/materials/Man-madeCellulosicFibres.html
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be "forward-looking" in nature within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNA's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to the possibility of a failure to make timely payment on its outstanding secured convertible notes and resulting enforcement by noteholders of remedies on collateral which includes substantially all of Applied DNA's assets, its history of net losses, limited financial resources, limited market acceptance, our ability to successfully enter into commercial contracts for the implementation of our CertainT(R) platform, and various other factors detailed from time to time in Applied DNA's SEC reports and filings, including our Annual Report on Form 10-K filed on December 12, 2019 and other reports we file with the SEC, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200127005182/en/
CONTACT: Investor contact
Sanjay M. Hurry, LHA Investor Relations
212-838-3777, shurry@lhai.com
Program contact
MeiLin Wan, VP Textile Sales
631-240-8849, meilin.wan@adnas.com
(END) Dow Jones Newswires
January 27, 2020 09:00 ET (14:00 GMT)
*DJ Applied DNA Says Granted U.S. Patent Protecting CertainT Platform in Man-Made Cellulosic Fibers, Materials
(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)
January 27, 2020 09:01 ET (14:01 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
新聞稿:應用dna宣佈頒發美國專利,保護其在人造纖維素纖維和材料中的確定性(R)平台。
應用dna宣佈美國在人造纖維素纖維和材料中保護其特定(R)平台的專利。
新發專利擴大公司在紡織供應鏈解決方案中的專利地位
紐約石溪-(商業電報)-2020年1月27日
應用DNA科學公司(納斯達克市場代碼:APDN)(“應用DNA”或“公司”),一家以聚合酶鏈反應(PCR)為基礎的用於產品真實性、可追溯性解決方案、核酸生物治療開發和液體活檢的DNA製造公司,今天宣佈,美國專利和商標局(USPTO)已將其授予美國專利編號10,519,605,題為“標識纖維素產品的方法”。新頒發的專利包括在生產過程中對人造纖維素(MMC)纖維或帶有核酸(Dna)標籤的材料進行標記的方法,以及隨後通過基於PCR的檢測技術對核酸標記的MMC纖維和/或材料進行驗證的方法,以確定來源和/或真實性。
全球MMC生產量翻了一番多,從300萬噸(1990年)增加到2018年的670萬噸(1),預計到2024年將繼續以每年9%的速度增長。MMCs包括粘膠、人造絲、醋酸酯、Lyocell、Tenel(R)、模態材料和Cupro材料。
大多數MMCs主要來源於木材。提高了對從瀕危森林或古森林採購木材原料的認識,提高了對生產中使用的化學品的社會和環境關切,以及用於製造甲基溴的能源和水的數量,從而加強了對甲基甲基溴工業的監督,並要求證明這些材料來自受控和可持續的來源,可以通過科學證據加以核實。
“MMC纖維和材料的使用正在推動紡織業走向更大的可持續性,但也引發了與森林砍伐和生物多樣性相關的社會和環境問題。作為迴應,H&M集團等品牌和零售商表達了一個目標,即在其產品中只使用經認證、負責任管理的MMC纖維。(3)它們正在積極加強採購政策,以解決這些問題。它們的主要舉措是將MMC供應鏈追溯到原料水平,”應用DNA紡織銷售副總裁萬美林(Melin Wan)表示。“有了這些新專利,再加上我們基於dna的線性標籤平台,我們可以為mmc纖維生產商和製造商提供無與倫比的能力,確保他們的品牌是真實和安全的。”
應用DNA公司戰略銷售副總裁韋恩·布欽(Wayne Buchen)説:“與MMC的來源、來源和真實性相關的透明度是解開與可持續和合乎道德的採購相關的寶貴主張的關鍵--這對供應鏈來説很重要,因為它們的產品和品牌從源頭到貨架都是安全的。”“該公司繼續與其MMC纖維生產商和製造商的全球網絡合作,以確保他們的品牌得到驗證和追蹤。隨着對源自某些地理位置的纖維素纖維的進一步審查,我們計劃提供解決方案,使我們的合作伙伴能夠通過我們的確定性門户網站對其產品進行數字驗證,並幫助我們的品牌合作伙伴通過我們為保護掛牌、線和包裝提供的其他解決方案來驗證他們的產品。我們非常高興現在將我們的專利技術提供給纖維素纖維和材料價值鏈的所有利益相關者。”
應用dna的董事長、總裁兼首席執行官詹姆斯·A·海沃德博士(Dr.James A.Hayward)説:“該公司處於大規模基於聚合酶鏈反應(PCR)的dna製造創新的前沿,其130多項待決專利申請和已頒發的專利“隨着這項專利的頒發,我們將繼續擴大紡織品專利確定平台的價值,這將是2020年財政年度的一個關鍵重點。”
(1)紡織品交易所,首選纖維和材料,2019年市場報告
(2)https://www.marketwatch.com/press-release/2019-24-cellulose-fiber-market-to-register-usd-39-bn-revenue-2019-07-22
(3)https://hmgroup.com/sustainability/Planet/materials/Man-madeCellulosicFibres.html
關於應用DNA科學
應用dna是一家提供分子技術的供應商,這些技術支持供應鏈安全、防偽和防盜技術、產品基因分型和臨牀前核酸治療藥物候選產品。
應用dna通過提供創新的、基於分子的技術解決方案和服務,幫助保護公司、政府和消費者的產品、品牌、整個供應鏈和知識產權免遭盜竊、偽造、欺詐和轉移,從而使生活變得真實和安全。
欲瞭解更多信息,請訪問adnas.com。在Twitter和LinkedIn上關注我們。加入我們的郵件列表。
在納斯達克上市的普通股代號為APDN。
前瞻性陳述
應用脱氧核糖核酸在本新聞稿中所作的陳述,可屬1933年“證券法”第27A條、1934年“證券交易法”第21E條及1995年“私人證券訴訟改革法”所指的“前瞻性”性質。前瞻性陳述描述了應用dna的未來計劃、預測、策略和預期,基於假設,涉及許多風險和不確定因素,其中許多風險和不確定性超出了應用dna的控制範圍。實際結果可能與預測的結果大相徑庭,原因是可能無法及時支付其未償還的可轉換擔保票據,並因此由票據持有人強制執行抵押品補救辦法,其中主要包括應用脱氧核糖核酸的所有資產、淨虧損的歷史、有限的財政資源、有限的市場接受程度、我們成功簽訂商業合同以實施我們的確定性(註冊商標)平台的能力,以及應用DNA證券交易委員會報告和文件中不時詳述的其他各種因素,包括我們於2019年12月12日提交的關於表10-K的年度報告以及我們向證券交易委員會提交的其他報告,這些報告可在www.sec.gov上查閲。除法律另有規定外,應用dna沒有義務公開更新任何前瞻性陳述,以反映本合同日期後的新信息、事件或情況,或反映意外事件的發生。
查看businesswire.com上的源代碼版本:https://www.businesswire.com/news/home/20200127005182/en/
聯繫人:投資者聯繫人
Sanjay M.先生,LHA投資者關係
212-838-3777
程序接觸
梅林萬,紡織銷售副總裁
電子郵件:meilin.wan@adnas.com
(完)道瓊斯通訊社
2020年01月27日09:00(格林尼治時間14:00)
*DJ應用dna説,美國授予了保護人造纖維素纖維、材料的特定平台的專利。
道瓊斯通訊社(212-416-2800)
2020年01月27日09:01(格林尼治時間14:01)
版權(C)2020 DowJones&Company,Inc.